ATX Therapeutics is a digital health company that empowers people to reach their health goals by enabling healthy behavior changes in individuals who either have, or are at risk of developing chronic diseases, such as cancer, heart disease and chronic obstructive pulmonary disease (COPD). Working with healthcare consumers, providers, researchers, health plans and employers, ATX Therapeutics creates evidence-based digital therapeutic products that deliver positive health outcomes while engaging patients to manage specific chronic health conditions and their associated risk behaviors. The company follows a human-centered and data-driven approach to product design, combining exceptional consumer-grade experiences with clinically-validated interventions to deliver sustainable results.